发明申请
US20060251728A1 Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
有权
1-氯-4-（β-D-吡喃葡萄糖-1-基）-2- [4 - （（R） - 四氢呋喃-3-基氧基） - 苄基] - 苯的结晶形式，其制备方法和 其用于制备药物
![Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments](/docs/US/2006-11-09/US20060251728A1/abs.jpg.600x600.jpg)
- 专利标题： Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
- 专利标题（中）： 1-氯-4-（β-D-吡喃葡萄糖-1-基）-2- [4 - （（R） - 四氢呋喃-3-基氧基） - 苄基] - 苯的结晶形式，其制备方法和 其用于制备药物
-
申请号： US11408899申请日： 2006-04-21
-
公开(公告)号： US20060251728A1公开(公告)日： 2006-11-09
- 发明人: Frank Himmelsbach , Sandra Schmid , Hans-Juergen Martin , Matthias Eckhardt , Martin Schuehle
- 申请人： Frank Himmelsbach , Sandra Schmid , Hans-Juergen Martin , Matthias Eckhardt , Martin Schuehle
- 申请人地址： DE Ingelheim
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim
- 优先权： EP05009670 20050503; EP05012195 20050607
- 主分类号： A61K9/14
- IPC分类号： A61K9/14
![Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments](/abs-image/US/2006/11/09/US20060251728A1/abs.jpg.150x150.jpg)
摘要：
The invention relates to crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.
公开/授权文献
信息查询
